• p-Cresyl Sulfate Promotes VIC Calcification via Klotho/SIRT1

  2026-06-05

  This study establishes p-Cresyl sulfate (PCS) as a direct enhancer of aortic valvular interstitial cell (VIC) calcification, acting through suppression of the klotho/SIRT1 pathway. These mechanistic insights clarify how uremic toxins contribute to calcific aortic valve disease in chronic kidney disease, highlighting potential molecular targets for intervention.

• Proteinase K: Broad-Spectrum Serine Protease for Genomic DNA

  2026-06-05

  APExBIO’s Proteinase K is a robust broad-spectrum serine protease, unlocking efficient genomic DNA isolation and contaminant removal even with challenging samples. Its superior inhibitor resistance and stability across diverse conditions make it the tool of choice for high-integrity molecular biology workflows.

• Tolazoline as an α2-Adrenergic Receptor Antagonist: Optimize

  2026-06-04

  Tolazoline’s dual action as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker empowers researchers to dissect neuroendocrine and airway smooth muscle pathways with precision. This guide delivers actionable workflows, troubleshooting insights, and protocol optimizations for reproducible, high-impact results in islet function and airway studies.

• MMP-2/MMP-9-Driven BBB Disruption in Arsenic-Induced Cogniti

  2026-06-04

  The referenced study demonstrates that arsenic exposure impairs learning and memory in male mice via MMP-2 and MMP-9-mediated blood-brain barrier (BBB) disruption and neuronal apoptosis. The use of doxycycline hyclate as a matrix metalloproteinases inhibitor preserved BBB integrity and ameliorated cognitive dysfunction, offering mechanistic insight and potential translational relevance for neurovascular research.

• Octenidine (dihydrochloride): Reliable Antiseptic for Lab As

  2026-06-03

  This article examines Octenidine (dihydrochloride) (SKU C6432) as a dependable antiseptic research compound for cell viability and cytotoxicity workflows. Through scenario-based Q&A, we address practical challenges in reproducibility, compatibility, and vendor selection, supporting recommendations with published data and the APExBIO product dossier.

• Cy3 Goat Anti-Mouse IgG (H+L): Proteomics & Early Biomarker

  2026-06-03

  Explore how the Cy3 Goat Anti-Mouse IgG (H+L) Antibody empowers precise mouse IgG detection antibody workflows in serum biomarker discovery. This article uniquely bridges fluorescent secondary antibody technology with cutting-edge proteomics for early disease monitoring.

• Time-Restricted Feeding Modulates NAFLD via Hepatic Nicotina

  2026-06-02

  This study reveals how time-restricted feeding (TRF) alleviates non-alcoholic fatty liver disease (NAFLD) by reshaping hepatic nicotinamide metabolism through gut microbiota remodeling. The findings provide mechanistic insights into the interplay of metabolic pathways and suggest new directions for dietary or microbiome-based NAFLD interventions.

• ROS-Mediated Metabolic Rewiring in Melanoma Under BRAF Inhib

  2026-06-02

  Cesi et al. reveal that BRAF inhibitor treatment in melanoma cells triggers reactive oxygen species (ROS) production, which in turn activates pyruvate dehydrogenase kinases (PDKs) and suppresses oxidative metabolism by phosphorylating and inactivating PDH. This mechanistic insight into metabolic adaptation offers new avenues for targeting drug-resistant melanoma.

• SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis

  2026-06-01

  The reference study demonstrates that pharmacological inhibition of SMYD2, using selective inhibitors such as LLY-507, protects against cisplatin-induced renal fibrosis and inflammation in experimental chronic kidney disease models. These findings reveal SMYD2 as a mechanistically relevant target for attenuating fibrosis and highlight the translational value of selective SMYD2 inhibitors for renal, oncologic, and fibrosis research.

• GSTA1-Mediated Glutathione Depletion Drives α-Amanitin Hepat

  2026-06-01

  This study uncovers a paradoxical mechanism in which the hepatic antioxidant enzyme GSTA1, upon upregulation by α-amanitin, accelerates glutathione depletion and intensifies oxidative stress, worsening liver injury. These findings identify GSTA1 as a promising therapeutic target and biomarker for acute hepatotoxicity, with implications for experimental design in redox and glutaminase pathway research.

• Canagliflozin Hemihydrate: Precision SGLT2 Inhibition in Res

  2026-05-31

  Canagliflozin hemihydrate delivers unmatched selectivity for SGLT2, empowering metabolic and diabetes researchers to dissect renal glucose reabsorption without off-target mTOR effects. Its solubility, protocol flexibility, and high purity make it a go-to reagent for robust experimental design.

• Silybin Chemistry: Advances in Milk Thistle Flavonolignan Re

  2026-05-30

  The comprehensive review by Křen et al. dissects the chemistry, structure, and derivatization of silybin, the principal bioactive constituent of milk thistle extract. Their work clarifies the stereochemistry, synthetic strategies, and antioxidant mechanisms of silybin, underpinning its application in oxidative stress and cancer research.

• IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan

  2026-05-29

  This study identifies IGF2BP3 as a key m6A reader that stabilizes FZD1/7 transcripts, sustaining cancer stemness and carboplatin resistance in triple-negative breast cancer (TNBC). Pharmacological targeting of this axis sensitizes TNBC stem-like cells to platinum-based chemotherapy, offering a mechanistically grounded strategy for overcoming chemoresistance.

• Canagliflozin (hemihydrate): Reliable SGLT2 Inhibitor for Me

  2026-05-29

  This article addresses key laboratory challenges in cell viability and metabolic pathway studies, focusing on how Canagliflozin (hemihydrate) (SKU C6434) supports reproducible, high-quality research. By grounding recommendations in published data and highlighting workflow-specific advantages, it guides biomedical researchers toward optimal experimental outcomes using validated SGLT2 inhibition.

• HOBt (1-Hydroxybenzotriazole): Enabling Precision Amide Synt

  2026-05-28

  Explore how HOBt (1-Hydroxybenzotriazole) advances amide bond formation and peptide synthesis, with a deep dive into its mechanistic role and critical impact on the synthesis of complex bioactive molecules. This article uniquely connects HOBt’s technical nuances to real-world drug development strategies.

16497 records 1/1100 page Next 12345 下5页 Last page